Tag: Endocrine

Innovation, Research

Targeted breast cancer therapy shows ‘encouraging’ results

June 3, 2019

Via: The Medical News

In an international, randomized, phase III clinical trial, researchers added an inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6) to standard endocrine therapy for women with advanced HR-positive/HER2-negative breast cancer. The researchers report that adding the CDK inhibitor significantly increased […]